BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP — Form D/A
BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP of WELLESLEY, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2022-12-01. The offering totals $350.0M, of which $204.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-12-01
- Form: D/A
- Accession: 0001835848-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $350.0M
- Amount sold: $204.5M
- Remaining: $145.5M
- Minimum investment: $500K
- Investors: 3
- Date of first sale: 2020-12-10
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-383341
Issuer
- Name: BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP
- CIK: 0001835848
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 16 LAUREL AVENUE, WELLESLEY, MA, 02481
- Phone: 7814892105
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jeffrey Barnes | Executive Officer | Odessa, FL |
| N/A BioVentures MedTech Growth Capital Management LLC | Executive Officer | WELLESLEY, MA |
| Jonathan Gertler | Executive Officer | WELLESLEY, MA |
| Marc Goldberg | Executive Officer | WORCESTER, MA |
| James Lousararian | Executive Officer | WORCESTER, MA |
Other filings by this issuer (2)
More